Concepedia

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

William C. Zamboni, Anne Gervais, Merrill J. Egorin, Jan H.M. Schellens, Elleanor G. Zuhowski, Dick Pluim, Erin Joseph, Deborah R. Hamburger, Peter K. Working, Gail Colbern,

Cancer Chemotherapy and Pharmacology · 2004 · 164 citations · 36 references

DOI

Concepts

References

36

Fundamentals of Biostatistics.

Annals of Internal Medicine · 1969 · 4.6K citations

, , +9

Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

Demetrios Papahadjopoulos, Theresa M. Allen, Alberto Gabizón et al. · Proceedings of the National Academy of Sciences · 1991 · 1.6K citations

, , +17

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

Franco M. Muggia, John D. Hainsworth, Susan Jeffers et al. · Journal of Clinical Oncology · 1997 · 657 citations

, , +17

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

Donald W. Northfelt, Bruce J. Dezube, James Thommes et al. · Journal of Clinical Oncology · 1998 · 642 citations

, , +16

Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.

Kevin J. Harrington, S. Mohammadtaghi, Paul S. Uster et al. · PubMed · 2001 · 578 citations

, , +17